ValiRx Balance Sheet Health
Financial Health criteria checks 3/6
ValiRx has a total shareholder equity of £4.0M and total debt of £27.1K, which brings its debt-to-equity ratio to 0.7%. Its total assets and total liabilities are £4.1M and £119.7K respectively.
Key information
0.7%
Debt to equity ratio
UK£27.08k
Debt
Interest coverage ratio | n/a |
Cash | UK£891.25k |
Equity | UK£3.95m |
Total liabilities | UK£119.67k |
Total assets | UK£4.07m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: VAL's short term assets (£1.4M) exceed its short term liabilities (£102.8K).
Long Term Liabilities: VAL's short term assets (£1.4M) exceed its long term liabilities (£16.8K).
Debt to Equity History and Analysis
Debt Level: VAL has more cash than its total debt.
Reducing Debt: VAL's debt to equity ratio has increased from 0% to 0.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if VAL has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if VAL has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.